Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

The recent reduction of live attenuated influenza vaccine (LAIV) effectiveness in multivalent formulations was particularly associated with the A(H1N1)pdm09 component. In the 2017 the WHO vaccine composition committee changed its recommendations for the A(H1N1)pdm09 component to include an A/Michiga...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vaccine X
Hlavní autoři: Shcherbik, Svetlana, Pearce, Nicholas, Carney, Paul, Bazhenova, Ekaterina, Larionova, Natalie, Kiseleva, Irina, Rudenko, Larisa, Kumar, Amrita, Goldsmith, Cynthia S., Dugan, Vivien, Stevens, James, Wentworth, David E., Bousse, Tatiana
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2019
Témata:
Regular paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668239/
https://ncbi.nlm.nih.gov/pubmed/31384746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvacx.2019.100031
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky